The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner

Journal of Cell Biology

Volumn 192, Issue 4, 2011, Pages 647-661

  Gauthier Kemper, Anne ^a   Weissmann, Carina ^a   Golovyashkina, Nataliya ^a   Sebö Lemke, Zsofia ^b   Drewes, Gerard ^c   Gerke, Volker ^d   Heinisch, Jürgen J ^a   Brandt, Roland ^a  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ION; LIPOCORTIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL GROWTH; CELL MEMBRANE; CHROMOSOME 17; CONTROLLED STUDY; CYTOSKELETON; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MEMBRANE BINDING; MICROTUBULE; MUTATION; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURIFICATION; R406W MUTATION; TANDEM MASS SPECTROMETRY; YEAST;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANNEXIN A2; BINDING SITES; CELL MEMBRANE; HUMANS; MICROTUBULES; MOLECULAR SEQUENCE DATA; NEURITES; PC12 CELLS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 79951873381     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201007161     Document Type: Article

References (52)

1. Aoyagi, H., M. Hasegawa, and A. Tamaoka. 2007. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J. Biol. Chem. 282:20309-20318. doi:10.1074/jbc.M611876200 (Pubitemid 47099993)
2. Biernat, J., N. Gustke, G. Drewes, E.M. Mandelkow, and E. Mandelkow. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11:153-163. doi:10.1016/0896-6273(93)90279-Z (Pubitemid 23222542)
3. Brajenovic, M., G. Joberty, B. Küster, T. Bouwmeester, and G. Drewes. 2004. Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J. Biol. Chem. 279:12804-12811. doi:10.1074/jbc.M312171200 (Pubitemid 38445853)
4. Brandt, R., J. Léger, and G. Lee. 1995. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131:1327-1340. doi:10.1083/jcb.131.5.1327
5. Bunker, J.M., K. Kamath, L. Wilson, M.A. Jordan, and S.C. Feinstein. 2006. FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells. J. Biol. Chem. 281:11856-11863. doi:10.1074/jbc.M509420200 (Pubitemid 43855446)
6. Busciglio, J., A. Lorenzo, J. Yeh, and B.A. Yankner. 1995. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:879-888. doi:10.1016/0896-6273(95)90232-5
7. Chang, E., S. Kim, H. Yin, H.N. Nagaraja, and J. Kuret. 2008. Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps. J. Neurochem. 107:1113-1123.
8. Connell, J.W., G.M. Gibb, J.C. Betts, W.P. Blackstock, J. Gallo, S. Lovestone, M. Hutton, and B.H. Anderton. 2001. Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS Lett. 493:40-44. doi:10.1016/S0014-5793(01)02267-0 (Pubitemid 32241173)
9. Cruz, J.C., and L.H. Tsai. 2004. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 10:452-458. doi:10.1016/j.molmed.2004.07. 001 (Pubitemid 39209212)
10. Dayanandan, R., M. Van Slegtenhorst, T.G. Mack, L. Ko, S.H. Yen, K. Leroy, J.P. Brion, B.H. Anderton, M. Hutton, and S. Lovestone. 1999. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 446:228-232. doi:10.1016/S0014-5793(99)00222-7 (Pubitemid 29132731)
11. DeTure, M., L.W. Ko, S.H. Yen, P. Nacharaju, C. Easson, J. Lewis, M. van Slegtenhorst, M. Hutton, and S.H. Yen. 2000. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res. 853:5-14. doi:10.1016/S0006-8993(99)02124-1 (Pubitemid 30015993)
12. DeTure, M., L.W. Ko, C. Easson, and S.H. Yen. 2002. Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am. J. Pathol. 161:1711-1722. doi:10.1016/S0002-9440(10)64448-3 (Pubitemid 35265530)
13. Dittgen, T., A. Nimmerjahn, S. Komai, P. Licznerski, J. Waters, T.W. Margrie, F. Helmchen, W. Denk, M. Brecht, and P. Osten. 2004. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc. Natl. Acad. Sci. USA. 101:18206-18211. doi:10.1073/pnas.0407976101 (Pubitemid 40054098)
14. Drubin, D., S. Kobayashi, D. Kellogg, and M. Kirschner. 1988. Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J. Cell Biol. 106:1583-1591. doi:10.1083/jcb.106.5. 1583
15. Eberhard, D.A., M.D. Brown, and S.R. VandenBerg. 1994. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am. J. Pathol. 145:640-649. (Pubitemid 24285971)
16. Eidenmüller, J., T. Fath, T. Maas, M. Pool, E. Sontag, and R. Brandt. 2001. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem. J. 357:759-767. doi:10.1042/0264-6021: 3570759 (Pubitemid 32735156)
17. Fath, T., J. Eidenmüller, and R. Brandt. 2002. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22:9733-9741. (Pubitemid 35332856)
18. Foster, N.L., K. Wilhelmsen, A.A. Sima, M.Z. Jones, C.J. D'Amato, and S. Gilman; Conference Participants. 1997. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41:706-715. doi:10.1002/ana.410410606 (Pubitemid 27249175)
19. Fox, M.T., D.A. Prentice, and J.P. Hughes. 1991. Increases in p11 and annexin II proteins correlate with differentiation in the PC12 pheochromocytoma. Biochem. Biophys. Res. Commun. 177:1188-1193. doi:10.1016/0006-291X(91)90666-U
20. Gerke, V., and S.E. Moss. 1997. Annexins and membrane dynamics. Biochim. Biophys. Acta. 1357:129-154. doi:10.1016/S0167-4889(97)00038-4 (Pubitemid 27278039)
21. Gerke, V., and S.E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371. (Pubitemid 34654456)
22. Gerke, V., C.E. Creutz, and S.E. Moss. 2005. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6:449-461. doi:10.1038/nrm1661 (Pubitemid 40780557)
23. Götz, J., and L.M. Ittner. 2008. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9:532-544. doi:10.1038/nrn2420 (Pubitemid 351873467)
24. Greene, L.A., M.M. Sobeih, and K.K. Teng. 1991. Methodologies for the culture and experimental use of the PC12 rat pheochromocytoma cell line. In Culturing Nerve Cells. G. Banker and K. Goslin, editors. MIT Press, Cambridge, Massachusetts. 207-226.
25. Hooper, C., R. Killick, and S. Lovestone. 2008. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104:1433-1439. doi:10.1111/j.1471-4159.2007. 05194.x (Pubitemid 351316776)
26. Ikeuchi, T., H. Kaneko, A. Miyashita, H. Nozaki, K. Kasuga, T. Tsukie, M. Tsuchiya, T. Imamura, H. Ishizu, K. Aoki, et al. 2008. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement. Geriatr. Cogn. Disord. 26:43-49. doi:10.1159/000141483
27. Jacovina, A.T., F. Zhong, E. Khazanova, E. Lev, A.B. Deora, and K.A. Hajjar. 2001. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J. Biol. Chem. 276:49350-49358. doi:10.1074/jbc.M106289200
28. Jeganathan, S., M. von Bergen, H. Brutlach, H.J. Steinhoff, and E. Mandelkow. 2006. Global hairpin folding of tau in solution. Biochemistry. 45:2283-2293. doi:10.1021/bi0521543 (Pubitemid 43271328)
29. Kirchrath, L., A. Lorberg, H.P. Schmitz, U. Gengenbacher, and J.J. Heinisch. 2000. Comparative genetic and physiological studies of the MAP kinase Mpk1p from Kluyveromyces lactis and Saccharomyces cerevisiae. J. Mol. Biol. 300:743-758. doi:10.1006/jmbi.2000.3916
30. Krishnamurthy, P.K., and G.V. Johnson. 2004. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J. Biol. Chem. 279:7893-7900. doi:10.1074/jbc.M311203200 (Pubitemid 38294676)
31. Leschik, J., A. Welzel, C. Weissmann, A. Eckert, and R. Brandt. 2007. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death. J. Neurochem. 101:1303-1315. doi:10.1111/j.1471-4159.2006.04435.x (Pubitemid 46718815)
32. Leugers, C.J., and G. Lee. 2010. Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding. J. Biol. Chem. 285:19125-19134. doi:10.1074/jbc.M110.105387
33. Lindquist, S.G., I.E. Holm, M. Schwartz, I. Law, J. Stokholm, M. Batbayli, G. Waldemar, and J.E. Nielsen. 2008. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur. J. Neurol. 15:377-385. doi:10.1111/j.1468-1331.2008.02069.x (Pubitemid 351422379)
34. Maas, T., J. Eidenmüller, and R. Brandt. 2000. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J. Biol. Chem. 275:15733-15740. doi:10.1074/jbc.M000389200 (Pubitemid 30366871)
35. Matsumura, N., T. Yamazaki, and Y. Ihara. 1999. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am. J. Pathol. 154:1649-1656. doi:10.1016/S0002-9440(10)65420-X (Pubitemid 29262846)
36. Miyasaka, T., M. Morishima-Kawashima, R. Ravid, P. Heutink, J.C. van Swieten, K. Nagashima, and Y. Ihara. 2001. Molecular analysis of mutant and wild-ype tau deposited in the brain affected by the FTDP-17 R406W mutation. Am. J. Pathol. 158:373-379. doi:10.1016/S0002-9440(10)63979-X (Pubitemid 32158599)
37. Morgan, R.O., and M.P. Fernández. 1997. Annexin gene structures and molecular evolutionary genetics. Cell. Mol. Life Sci. 53:508-515. doi:10.1007/s000180050064 (Pubitemid 27374491)
38. Ostojic, J., C. Elfgren, U. Passant, K. Nilsson, L. Gustafson, L. Lannfelt, and S. Froelich Fabre. 2004. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement. Geriatr. Cogn. Disord. 17:298-301. doi:10.1159/000077158 (Pubitemid 38721145)
39. Patterson, G.H., and J. Lippincott-Schwartz. 2002. A photoactivatable GFP for selective photolabeling of proteins and cells. Science. 297:1873-1877. doi:10.1126/science.1074952
40. Piperno, G., M. LeDizet, and X.J. Chang. 1987. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J. Cell Biol. 104:289-302. doi:10.1083/jcb.104.2.289
41. Rescher, U., and V. Gerke. 2004. Annexins-unique membrane binding proteins with diverse functions. J. Cell Sci. 117:2631-2639. doi:10.1242/jcs.01245 (Pubitemid 38997247)
42. Rizzu, P., J.C. Van Swieten, M. Joosse, M. Hasegawa, M. Stevens, A. Tibben, M.F. Niermeijer, M. Hillebrand, R. Ravid, B.A. Oostra, et al. 1999. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 64:414-421. doi:10.1086/302256 (Pubitemid 129500524)
43. Schlaepfer, D.D., and H.T. Haigler. 1990. Expression of annexins as a function of cellular growth state. J. Cell Biol. 111:229-238. doi:10.1083/jcb.111.1.229
44. Spillantini, M.G., R.A. Crowther, and M. Goedert. 1996. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol. 92:42-48. doi:10.1007/s004010050487 (Pubitemid 26192081)
45. Sprague, B.L., R.L. Pego, D.A. Stavreva, and J.G. McNally. 2004. Analysis of binding reactions by fluorescence recovery after photobleaching. Biophys. J. 86:3473-3495. doi:10.1529/biophysj.103.026765 (Pubitemid 38780231)
46. Stoothoff, W.H., and G.V. Johnson. 2005. Tau phosphorylation: physiological and pathological consequences. Biochim. Biophys. Acta. 1739:280-297. (Pubitemid 40018545)
47. Tackenberg, C., and R. Brandt. 2009. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J. Neurosci. 29:14439-14450. doi:10.1523/JNEUROSCI.3590-09.2009
48. Thiel, C., M. Osborn, and V. Gerke. 1992. The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J. Cell Sci. 103:733-742. (Pubitemid 23023243)
49. Vogelsberg-Ragaglia, V., J. Bruce, C. Richter-Landsberg, B. Zhang, M. Hong, J.Q. Trojanowski, and V.M. Lee. 2000. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol. Biol. Cell. 11:4093-4104.
50. Weissmann, C., H.J. Reyher, A. Gauthier, H.J. Steinhoff, W. Junge, and R. Brandt. 2009. Microtubule binding and trapping at the tip of neurites regulate tau motion in living neurons. Traffic. 10:1655-1668. doi:10.1111/j.1600-0854. 2009.00977.x
51. Yoshiyama, Y., V.M. Lee, and J.Q. Trojanowski. 2001. Frontotemporal dementia and tauopathy. Curr. Neurol. Neurosci. Rep. 1:413-421. doi:10.1007/s11910-001-0100-0
52. Zhang, B., M. Higuchi, Y. Yoshiyama, T. Ishihara, M.S. Forman, D. Martinez, S. Joyce, J.Q. Trojanowski, and V.M. Lee. 2004. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24:4657-4667. doi:10.1523/JNEUROSCI.0797-04.2004 (Pubitemid 38656621)